About Nanostim
Nanostim is a company based in Sunnyvale (United States) founded in 2007 was acquired by St. Jude Medical in October 2013.. Nanostim has raised $30.2 million across 4 funding rounds from investors including St. Jude Medical, Emergent Medical Partners and USVP. Nanostim operates in a competitive market with competitors including AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30.2 M (USD)
in 4 rounds
-
Latest Funding Round
$9.5 M (USD), Series B
May 03, 2013
-
Investors
St. Jude Medical
& 3 more
-
Employee Count
Employee Count
-
Acquired by
St. Jude Medical
(Oct 14, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nanostim
Nanostim has successfully raised a total of $30.2M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $9.5 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $9.5M
-
First Round
First Round
(31 Oct 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2013 | Amount | Series B - Nanostim | Valuation |
investors |
|
| Oct, 2012 | Amount | Series B - Nanostim | Valuation | Emergent Medical Partners , USVP |
|
| Feb, 2011 | Amount | Series A - Nanostim | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nanostim
Nanostim has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include St. Jude Medical, Emergent Medical Partners and USVP. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding and expertise are provided for medical device development.
|
Founded Year | Domain | Location | |
|
VC firm that focuses on early stage investments in the US
|
Founded Year | Domain | Location | |
|
Early-stage investing in IT and healthcare ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanostim
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nanostim
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanostim Comparisons
Competitors of Nanostim
Nanostim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| domain | founded_year | HQ Location |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| domain | founded_year | HQ Location |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| domain | founded_year | HQ Location |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| domain | founded_year | HQ Location |
Mapping catheters for cardiac arrhythmia treatment are developed.
|
|
| domain | founded_year | HQ Location |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanostim
Frequently Asked Questions about Nanostim
When was Nanostim founded?
Nanostim was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Nanostim located?
Nanostim is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is Nanostim a funded company?
Nanostim is a funded company, having raised a total of $30.2M across 4 funding rounds to date. The company's 1st funding round was a Series A of $1M, raised on Oct 31, 2008.
What does Nanostim do?
Nanostim was founded in 2007 in Sunnyvale, United States, as a medical device company focused on leadless pacing technology. Wireless pacemakers were developed to advance cardiac rhythm management without traditional leads. The product received CE Mark approval, and the company was acquired by St. Jude Medical Inc. for 123.5 million in October 2013, integrating the technology into broader operations.
Who are the top competitors of Nanostim?
Nanostim's top competitors include AtaCor Medical, AtriCure and CardioFocus.
Who are Nanostim's investors?
Nanostim has 4 investors. Key investors include St. Jude Medical, Emergent Medical Partners, USVP, and InterWest.